FDA Approves Updated COVID-19 Shots from Pfizer, Moderna, Novavax with New Restrictions on August 29, 2025 COVID19 (disease) high-risk groups LP.8.1 sublineage Moderna Novavax Pfizer Restrictions United States Food and Drug Administration Vaccines +
Novavax Approval Process Raises Concerns Among Former Regulators About FDA Integrity on June 27, 2025 Approved concerns COVID19 (disease) delays Intact Interferes with Novavax political Regulation of biological process United States Food and Drug Administration Vaccines +
FDA Approves Novavax COVID Vaccine After Delay, Limits Use to Smaller High-Risk Population on May 19, 2025 Approved COVID19 (disease) Elderly (population group) Health conditions:-:Point in time:^Patient:- Novavax protein-based vaccine restricted population United States Food and Drug Administration Vaccines +
Novavax's COVID-19 jab looks to be on track for approval on April 24, 2025 Approved COVID19 (disease) Novavax Novavax 's United States Food and Drug Administration Vaccines +
FDA official said to step in and pause review of Novavax's COVID-19 vaccine on April 04, 2025 Approved COVID19 (disease) Novavax Novavax 's Review [Publication Type] United States Food and Drug Administration Vaccines +